Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HELX
Franklin Genomic Advancements ETF
38.7
0
USD
-0.01%
Sector:
Financial
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.72%
Monthly Change
+1.76%
6 month change
+13.46%
Year Change
+13.46%
Previous Close
38.9
8
Open
38.7
0
Low
38.7
0
High
38.7
0
Volume
1
Markets
US ETFs
HELX
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Overview
All holdings
Heatmap
Top holdings
Market Value
Shares
Weight %
GH
Guardant Health Inc
1.45 M
15.72 K
6.77%
NTRA
NATERA INC
1.43 M
7 131.00
6.65%
KRYS
Krystal Biotech Inc
1.14 M
4 418.00
5.32%
UTHR
United Therapeutics Corporation
996.21 K
1 680.00
4.64%
INSM
Insmed Inc
970.00 K
5 932.00
4.52%
BBIO
Bridgebio Pharma Inc
905.38 K
12.19 K
4.22%
LGND
Ligand Pharmaceuticals Incorporated
757.47 K
3 794.00
3.53%
A
AZN
AstraZeneca PLC
728.73 K
3 695.00
3.40%
ADPT
Adaptive Biotechnologies Corp
669.64 K
48.24 K
3.12%
VRTX
Vertex Pharmaceuticals Incorporated
640.78 K
1 435.00
2.99%
Samsung Biologics Co Ltd
640.23 K
652.00
2.99%
MEDP
Medpace Holdings Inc.
637.21 K
1 327.00
2.97%
REGN
Regeneron Pharmaceuticals, Inc.
577.93 K
748.00
2.69%
CTVA
Corteva Inc
577.93 K
6 904.00
2.69%
ALNY
Alnylam Pharmaceuticals Inc.
558.18 K
1 687.00
2.60%
LLY
Eli Lilly & Co.
545.42 K
593.00
2.54%
IONS
Ionis Pharmaceuticals, Inc.
447.31 K
5 957.00
2.09%
TEM
Tempus AI Inc.
394.59 K
8 726.00
1.84%
BNTX
BioNTech SE
385.74 K
4 340.00
1.80%
NBIX
Neurocrine Biosciences Inc
354.78 K
2 693.00
1.65%
1
2
3
News
The Steepener Was Built On A Barrel Of Oil
This Week's Market Wrap: AI Shakeup, Earnings, And Renewed Oil Shock
The Next Big Theme: July 2026
Equity Outlook Q3 2026: Broadening Earnings Growth Meets Elevated Volatility
It's Not All About AI: Where To Find Other Potential Market Opportunities
Healthcare Investing: Finding Growth Beyond Pharmaceuticals
America At 250: Built On Reinvention, Powered By Innovation
Biotech Is The Rate Cut Trade In Disguise
The Disinflation Trade Has A New Address: Genomics
Healthcare's Quiet Comeback: Innovation, Obesity Drugs And New Opportunities
Health Care Flies High
First Quarter Earnings: Sharpening Sector Divergence